Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: HLA class II molecule HLA-DRA identifies immuno-hot tumors and predicts the therapeutic response to anti-PD-1 immunotherapy in NSCLC

Fig. 2

Expression patterns and prognostic values of potential biomarkers. A Expression levels of seven candidates in tumor and para-tumor tissues in NSCLC. B Cell subsets of seven candidates’ expressions in NSCLC. The data was obtained from the TISCH database. C Prognostic values of seven candidates in NSCLC. D Prognostic values of seven candidates in LUAD. E Prognostic values of seven candidates in LUSC

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us